Resources

October 12, 2020
In 2019, Jeni Doerr finally received a diagnosis for her recent illnesses – pancolitis. Biosimilars proved to be an effective treatment, Jeni says, "Biosimilars truly gave me my life back!"
increasing access to biosimilars act
October 12, 2020
Patent abuse and anti-competitive activities limit the ability of biosimilars to reach the market in a timely manner and ultimately hurt patients.
Biosimilars News May 2020
October 5, 2020
The biosimilar development process has three major stages: characterization and perfecting the process, confirmation of biosimilarity and approval.
twitter chat
September 28, 2020
IGBA released a new policy paper about developing a regulatory framework supporting biosimilar competition.
biosimilars news january 2020
September 28, 2020
The Biosimilars Council has identified the key issues that stand in the way of patient access to biosimilar medicines.
Approved Biosimilars
September 21, 2020
Biosimilars are biologic medicines that are highly similar to a previously approved reference biologic currently on the market. But what does that short definition of a biosimilar actually mean?

Want to keep up to date with the biosimilars industry?

Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.

SIGN UP FOR OUR NEWSLETTER